Resequencing of genes for transforming growth factor β1 (<it>TGFB1</it>) type 1 and 2 receptors (<it>TGFBR1</it>, <it>TGFBR2</it>), and association analysis of variants with diabetic nephropathy
<p>Abstract</p> <p>Background</p> <p>Diabetic nephropathy is the leading cause of end stage renal failure in the western world. There is substantial epidemiological evidence supporting a genetic predisposition to diabetic nephropathy, however the exact molecular mechani...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2007-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_1b10f67cbbde49a99a72806cdae83bf0 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Patterson Chris C |e author |
700 | 1 | 0 | |a Savage David A |e author |
700 | 1 | 0 | |a McKnight Amy |e author |
700 | 1 | 0 | |a Sadlier Denise |e author |
700 | 1 | 0 | |a Maxwell A Peter |e author |
245 | 0 | 0 | |a Resequencing of genes for transforming growth factor β1 (<it>TGFB1</it>) type 1 and 2 receptors (<it>TGFBR1</it>, <it>TGFBR2</it>), and association analysis of variants with diabetic nephropathy |
260 | |b BMC, |c 2007-02-01T00:00:00Z. | ||
500 | |a 10.1186/1471-2350-8-5 | ||
500 | |a 1471-2350 | ||
520 | |a <p>Abstract</p> <p>Background</p> <p>Diabetic nephropathy is the leading cause of end stage renal failure in the western world. There is substantial epidemiological evidence supporting a genetic predisposition to diabetic nephropathy, however the exact molecular mechanisms remain unknown. Transforming growth factor (TGFβ1) is a crucial mediator in the pathogenesis of diabetic nephropathy.</p> <p>Methods</p> <p>We investigated the role of five known single nucleotide polymorphisms (SNPs) in the <it>TGFB1 </it>gene for their association with diabetic nephropathy in an Irish, type 1 diabetic case (n = 272) control (n = 367) collection. The activity of TGFβ1 is facilitated by the action of type 1 and type 2 receptors, with both receptor genes (<it>TGFBR1 </it>and <it>TGFBR2</it>) shown to be upregulated in diabetic kidney disease. We therefore screened <it>TGFBR1 </it>and <it>TGFBR2 </it>genes for genomic variants using WAVE™ (dHPLC) technology and confirmed variants by direct capillary sequencing. Allele frequencies were determined in forty-eight healthy individuals. Data for all SNPs was assessed for Hardy Weinberg equilibrium, with genotypes and allele frequencies compared using the χ<sup>2 </sup>test for contingency tables. Patterns of linkage disequilibrium were established and common haplotypes estimated.</p> <p>Results</p> <p>Fifteen variants were identified in these genes, seven of which are novel, and putatively functional SNPs were subsequently genotyped using TaqMan™, Invader™ or Pyrosequencing<sup>® </sup>technology. No significant differences (<it>p </it>> 0.1) were found in genotype or allele distributions between cases and controls for any of the SNPs assessed.</p> <p>Conclusion</p> <p>Our results suggest common variants in <it>TGFB1</it>, <it>TGFBR1 </it>and <it>TGFBR2 </it>genes do not strongly influence genetic susceptibility to diabetic nephropathy in an Irish Caucasian population.</p> | ||
546 | |a EN | ||
690 | |a Internal medicine | ||
690 | |a RC31-1245 | ||
690 | |a Genetics | ||
690 | |a QH426-470 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BMC Medical Genetics, Vol 8, Iss 1, p 5 (2007) | |
787 | 0 | |n http://www.biomedcentral.com/1471-2350/8/5 | |
787 | 0 | |n https://doaj.org/toc/1471-2350 | |
856 | 4 | 1 | |u https://doaj.org/article/1b10f67cbbde49a99a72806cdae83bf0 |z Connect to this object online. |